Alvotech Strikes $45m Deal With Yas Holding

Biosimilars Deal Includes 2.5% Stake And MENA Rights

 
• By Dave Wallace

Alvotech has struck an investment deal worth $45m that will give Yas Holding a 2.5% stake in the business, as well as rights to sell three Alvotech biosimilars in the MENA region.

Syringe
The deal gives Alvotech another injection of cash following Fuji Pharma’s $50m investment announced last year • Source: Shutterstock

More from Deals

More from Business